Ubs Group Ag Orasure Technologies Inc Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Orasure Technologies Inc stock. As of the latest transaction made, Ubs Group Ag holds 1,561,018 shares of OSUR stock, worth $5.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,561,018

Previous 32,017 4775.59%

Holding current value

$5.26 Million

Previous $136,000 4043.38%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.58 - $4.4 $5.47 Million - $6.73 Million	1,529,001 Added 4775.59%	1,561,018 $5.64 Million
Q3 2024 Nov 14, 2024	SELL	$3.93 - $4.59 $46,432 - $54,230	-11,815 Reduced 26.96%	32,017 $136,000
Q2 2024 Aug 13, 2024	SELL	$4.2 - $6.18 $116,671 - $171,674	-27,779 Reduced 38.79%	43,832 $186,000
Q1 2024 May 13, 2024	BUY	$6.08 - $8.28 $204,525 - $278,530	33,639 Added 88.59%	71,611 $440,000
Q4 2023 Feb 09, 2024	BUY	$5.13 - $8.35 $62,149 - $101,160	12,115 Added 46.85%	37,972 $311,000
Q3 2023 Nov 09, 2023	SELL	$4.4 - $6.91 $132,189 - $207,597	-30,043 Reduced 53.74%	25,857 $153,000
Q2 2023 Aug 11, 2023	BUY	$4.88 - $7.39 $124,347 - $188,304	25,481 Added 83.77%	55,900 $280,000
Q1 2023 May 12, 2023	SELL	$4.66 - $6.52 $39,153 - $54,781	-8,402 Reduced 21.64%	30,419 $184,000
Q4 2022 Feb 08, 2023	BUY	$3.7 - $5.29 $102,134 - $146,025	27,604 Added 246.09%	38,821 $187,000
Q3 2022 Nov 10, 2022	BUY	$2.72 - $4.61 $13,774 - $23,345	5,064 Added 82.3%	11,217 $42,000
Q2 2022 Aug 10, 2022	SELL	$2.71 - $7.12 $62,351 - $163,816	-23,008 Reduced 78.9%	6,153 $17,000
Q1 2022 May 16, 2022	SELL	$6.62 - $9.33 $186,266 - $262,518	-28,137 Reduced 49.11%	29,161 $197,000
Q4 2021 Feb 14, 2022	BUY	$8.3 - $11.29 $353,098 - $480,299	42,542 Added 288.3%	57,298 $498,000
Q3 2021 Nov 15, 2021	SELL	$9.73 - $13.38 $121,333 - $166,848	-12,470 Reduced 45.8%	14,756 $167,000
Q2 2021 Aug 13, 2021	SELL	$9.02 - $11.68 $161,611 - $209,270	-17,917 Reduced 39.69%	27,226 $276,000
Q1 2021 May 12, 2021	SELL	$9.53 - $15.42 $126,720 - $205,039	-13,297 Reduced 22.75%	45,143 $527,000
Q4 2020 Feb 11, 2021	BUY	$10.35 - $15.94 $110,351 - $169,952	10,662 Added 22.32%	58,440 $618,000
Q3 2020 Nov 12, 2020	BUY	$10.24 - $19.58 $28,098 - $53,727	2,744 Added 6.09%	47,778 $582,000
Q2 2020 Jul 31, 2020	SELL	$9.71 - $17.87 $3.37 Million - $6.2 Million	-347,111 Reduced 88.52%	45,034 $525,000
Q1 2020 May 01, 2020	SELL	$5.57 - $10.76 $151,509 - $292,682	-27,201 Reduced 6.49%	392,145 $4.22 Million
Q4 2019 Feb 14, 2020	BUY	$7.21 - $8.89 $2.67 Million - $3.29 Million	369,713 Added 744.89%	419,346 $3.37 Million
Q3 2019 Nov 14, 2019	BUY	$6.57 - $9.46 $238,247 - $343,047	36,263 Added 271.23%	49,633 $371,000
Q2 2019 Aug 14, 2019	BUY	$8.17 - $11.07 $76,887 - $104,179	9,411 Added 237.71%	13,370 $124,000
Q1 2019 May 14, 2019	SELL	$9.63 - $13.09 $212,986 - $289,511	-22,117 Reduced 84.82%	3,959 $44,000
Q4 2018 Feb 14, 2019	BUY	$10.53 - $15.54 $93,853 - $138,508	8,913 Added 51.93%	26,076 $304,000
Q3 2018 Nov 14, 2018	BUY	$15.25 - $17.72 $65,483 - $76,089	4,294 Added 33.37%	17,163 $265,000
Q2 2018 Aug 14, 2018	BUY	$14.46 - $18.08 $74,584 - $93,256	5,158 Added 66.89%	12,869 $212,000
Q1 2018 May 15, 2018	SELL	$16.77 - $22.04 $16,417 - $21,577	-979 Reduced 11.27%	7,711 $130,000
Q4 2017 Feb 14, 2018	SELL	$13.44 - $22.81 $78,583 - $133,370	-5,847 Reduced 40.22%	8,690 $163,000
Q3 2017 Nov 14, 2017	BUY	$19.97 - $22.74 $7,628 - $8,686	382 Added 2.7%	14,537 $327,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,015 Added 98.25%	14,155 $244,000
Q1 2017 Nov 14, 2017	BUY	N/A	7,140	7,140 $93,000

Others Institutions Holding OSUR

# of Institutions

205

Shares Held

67.6M

Call Options Held

6.3K

Put Options Held

11.1K

View Full List

About ORASURE TECHNOLOGIES INC

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $245M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

More about OSUR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account